CytRx Corp (CYTR) Approves One-for-Seven Reverse Split
Tweet
Share
E-mailGet Alerts CYTR Hot Sheet
Join SI Premium – FREE
CytRx Corporation (Nasdaq: CYTR), announced a reverse split of its common stock at a ratio of 1-for-7. CytRx’s common stock will begin trading on NASDAQ on a split-adjusted basis when the market opens on May 16, 2012. The Company’s Board of Directors unanimously approved the reverse split following stockholder approval, which was announced at the Company’s 2012 Annual Meeting of Stockholders held May 14, 2012.
The reverse split will reduce the number of outstanding shares of the Company’s common stock from approximately 149.1 million shares to approximately 21.3 million shares. Fractional shares as a result of the reverse stock split will be rounded up to the next whole number. Proportional adjustments will be made to CytRx’s outstanding warrants and stock options. The Company's authorized shares will remain unchanged.
The reverse split will reduce the number of outstanding shares of the Company’s common stock from approximately 149.1 million shares to approximately 21.3 million shares. Fractional shares as a result of the reverse stock split will be rounded up to the next whole number. Proportional adjustments will be made to CytRx’s outstanding warrants and stock options. The Company's authorized shares will remain unchanged.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DBGI Corp. to execute 1-for-40 reverse stock split on July 24
- Splash Beverage Group sets 1-for-4 reverse stock split after trading halt
- J. M. Smucker (SJM) Raises Quarterly Dividend 1.8% to $1.12; 4% Yield
Create E-mail Alert Related Categories
Stock SplitsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
